Get the real deal on beauty treatments—real doctors, real reviews, and real photos with real results.Here's how we earn your trust.

POSTED UNDER Latisse REVIEWS

Latisse is Dangerous

ORIGINAL POST

Legally blind because this was used in my...

closeoutconnection
$2,200
Legally blind because this was used in my eyelashes for 3 years. I have corneal dystrophy in both eyes and legally blind. Do not buy this product. Many doctors will not even sell it. This drug was first used treating glaucoma but druggists suddenly realized it made eyelashes longer. I am now a victim with damaged eyes.

closeoutconnection's provider

Latisse allergan

Overall rating
Doctor's bedside manner
Answered my questions
After care follow-up
Time spent with me
Phone or email responsiveness
Staff professionalism & courtesy
Payment process
Wait times

The product is defective.

Replies (24)

December 7, 2015

Thank you for sharing on RealSelf.  I hope you find support in our community.

December 7, 2015
Thank you
December 8, 2015
Oh I'm so sorry
December 8, 2015
But latisse if ur going to use it for eye lashes u put it on the top of ur line lashes. Like if u are going to put eyeliner . Hope this helps
December 8, 2015
I did. And now I have permanent eye damage.
December 31, 2015
it still affects your eyes!!
December 9, 2015
This doesn't seem right. Latisse was developed from prescription drops used to treat Glaucoma. The worse that can happen if you applied this DIRECTLY TO YOUR CORNEA is a darkening of your eye. I'm pretty sure if it caused blindness the FDA would take it off the market. I would investigate more it to what actually caused this.
December 31, 2015
You are wrong...do some research.
December 11, 2015
Corneal dystrophy is a genetic, inherited disorder. It cannot be caused by outside factors, such as injury. Your diagnosis doesn't seem to jive with an injury caused by Latisse.
December 19, 2015

Jill, can you remove this review? This person (closeout connection) is a troll.

December 19, 2015
I am sure lawsuits will be popping up. We will see.